Physician
Mid-Atlantic Pain Specialists LLC
Mid-Atlantic Pain Specialists LLC was paid $1.74M by Medicaid between Jan 2018 and Nov 2024, across 33 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 46% of everything it billed.
33Billing provider infoMID-ATLANTIC PAIN SPECIALISTS LLC
VINELAND, NJ 08361
VINELAND, NJ 08361
33aNPI1023415023assigned 11/20/2014
33bProvider typeInterventional Pain Medicine Physician
28Total paid$1.74M
24GClaims43,059
24DCodes billed33
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Interventional Pain Medicine Physician providers in New Jersey
Rank by total paid#1 of 13
Median peer was paid$6K
This provider vs. median315×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 3,993 | $210K | |
| 2019 | 3,864 | $120K | |
| 2020 | 5,308 | $242K | |
| 2021 | 4,303 | $187K | |
| 2022 | 10,244 | $307K | |
| 2023 | 9,019 | $402K | |
| 2024incomplete | 6,328 | $272K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 46% | 20,089 | 18,237 | $796K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 18% | 10,167 | 9,671 | $312K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 12% | 2,054 | 1,938 | $202K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 7.0% | 3,471 | 3,256 | $121K |
| H0006 | Alcohol and/or drug services; case management | 5.4% | 1,329 | 1,038 | $95K |
| 64483 | 3.4% | 332 | 327 | $59K | |
| L0648 | Lumbar-sacral orthosis, sagittal control, with rigid anterior and posterior panels, posterior extends from sacrococcygeal junction to t-9 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, prefabricated, off-the-shelf | 2.7% | 126 | 122 | $46K |
| 99244 | Office or other outpatient consultation, moderate to high complexity | 1.9% | 304 | 303 | $34K |
| 64484 | 1.4% | 253 | 248 | $24K | |
| 99401 | <1% | 1,343 | 1,241 | $17K | |
| 62323 | <1% | 174 | 170 | $14K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 233 | 222 | $6K |
21 more codes
| 80305 | <1% | 917 | $4K | |
| 64493 | <1% | 68 | $3K | |
| 99243 | <1% | 25 | $3K | |
| 20610 | <1% | 58 | $2K | |
| 64494 | <1% | 54 | $853.32 | |
| 99407 | <1% | 68 | $604.32 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 16 | $6.76 |
| G8483 | Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) | 0% | 117 | $0.00 |
| G8482 | Influenza immunization administered or previously received | 0% | 90 | $0.00 |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 329 | $0.00 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 380 | $0.00 |
| 77003 | 0% | 176 | $0.00 | |
| 4004F | 0% | 131 | $0.00 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 0% | 14 | $0.00 |
| G8752 | Most recent systolic blood pressure < 140 mmhg | 0% | 28 | $0.00 |
| 1036F | 0% | 222 | $0.00 | |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | 0% | 212 | $0.00 |
| G9906 | Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy) | 0% | 115 | $0.00 |
| G9902 | Patient screened for tobacco use and identified as a tobacco user | 0% | 123 | $0.00 |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 29 | $0.00 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCHAPDELAINE, ROBERT (PRESIDENT)